Epstein-Barr Virus Infection and Altered Control of Apoptotic Pathways in Posttransplant Lymphoproliferative Disorders

Abstract

Posttransplant lymphoproliferative disorders (PTLD) represent a spectrum of lymphoid diseases complicating the clinical course of transplant recipients. Most PTLD are Epstein-Barr virus (EBV) associated with viral latency type III. Several in vitro studies have revealed an interaction between EBV latency proteins and molecules of the apoptosis pathway. Data on human PTLD regarding an association between Bcl-2 family proteins and EBV are scarce. We analyzed 60 primary PTLD for expression of 8 anti- (Bcl-2, Bcl-XL, and Mcl-1) and proapoptotic proteins (Bak and Bax), the so-called BH3-only proteins (Bad, Bid, Bim, and Puma), as well as the apoptosis effector cleaved PARP by immunohistochemistry. Bim and cleaved PARP were both significantly (p = 0.001 and p = 5.251e-6) downregulated in EBV-positive compared to EBV-negative PTLD [Bim: 6/40 (15%), cleaved PARP: 10/43 (23%), vs. Bim: 13/16 (81%), cleaved PARP: 12/17 (71%)]. Additionally, we observed a tendency toward increased Bcl-2 protein expression (p = 0.24) in EBV-positive PTLD. Hence, we provide evidence of a distinct regulation of Bcl-2 family proteins in EBV-positive versus negative PTLD. The low-expression pattern of the proapoptotic proteins Bim and cleaved PARP together with the high-expression pattern of the antiapoptotic protein Bcl-2 by trend in EBV-positive tumor cells suggests disruption of the apoptotic pathway by EBV in PTLD, promoting survival signals in the host cells.

Lymphoproliferative Disorders after Lung Transplantation: Clinicopathological Characterization of 16 Cases with Identification of Very-Late-Onset Forms

“…Solid organ and bone marrow transplant recipients have an increased risk of developing lymphoproliferations as a consequence of immunosuppression [1,2]. These rare lesions are called posttransplant lymphoproliferative disorders (PTLD), and most are Epstein-Barr virus (EBV) related.…”

Anticancer compound ABT-263 accelerates apoptosis in virus-infected cells and imbalances cytokine production and lowers survival rates of infected mice

“…8, 9, 10, 11, 12, 13, 14, 15, 16 In addition to mitochondria-initiated apoptosis, the replication of these microbes is associated with the caspase-8-FADD (FAS-associating death domain-containing protein)-mediated apoptosis pathway. 17 We hypothesised that the chemical inhibitors of Bcl-2, Bcl-xL and Bcl-w could accelerate the death of virus-infected cells by enhancing caspase-mediated cross-talk between mitochondria and death receptor apoptosis pathways.…”

Chrysotile Causes Human Bronchial Epithelial Cell Apoptosis in Response to the Fas-Mediated Apoptosis Pathway

“…It is known that apoptosis is an intrinsic cell suicide program through a distinct form of cell death control to remove cells from the body without inducing inflammation [15,16] . It seems to be a physiological mechanism for apoptosis in mitochondria-dependent and mitochondria-independent pathways.…”